NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 120 filers reported holding NURIX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $989,095 | -9.0% | 125,839 | +15.6% | 0.00% | 0.0% |
| Q2 2023 | $1,087,412 | +18.0% | 108,850 | +4.9% | 0.00% | 0.0% |
| Q1 2023 | $921,558 | -21.2% | 103,779 | -2.5% | 0.00% | -33.3% |
| Q4 2022 | $1,169,139 | +32.6% | 106,479 | +57.4% | 0.01% | +20.0% |
| Q3 2022 | $882,000 | +425.0% | 67,655 | +410.0% | 0.01% | +400.0% |
| Q2 2022 | $168,000 | -7.7% | 13,265 | +2.0% | 0.00% | 0.0% |
| Q1 2022 | $182,000 | -51.6% | 13,005 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $376,000 | – | 13,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |